Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Levitzki

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
BMC Systems Biology|March 18, 2011
Convergence of logic of cellular regulation in different premalignant cells by an information theoretic approachNataly Kravchenko-Balasha, F Remacle, Ayelet Gross, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2002
Tyrosine kinase inhibitors suppress the growth of non-hodgkin B lymphomasHannah Ben-Bassat, Zipora Hartzstark, Rubina Levitzki, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2012
On a fundamental structure of gene networks in living cellsNataly Kravchenko-Balasha, Alexander Levitzki, Andrew Goldstein, et al.
Experimental and Molecular Pathology|May 6, 2004
The effect of early and late treatment with the tyrphostin AG-556 on the progression of experimental autoimmune myocarditisJacob George, Iris Barshack, Iris Goldberg, et al.
International Journal of Cancer|September 5, 2002
Labeled EGFr-TK irreversible inhibitor (ML03): in vitro and in vivo properties, potential as PET biomarker for cancer and feasibility as anticancer drugGiuseppina Ortu, Iris Ben-David, Yulia Rozen, et al.
Nuclear Medicine and Biology|April 20, 2004
Novel carbon-11 labeled 4-dimethylamino-but-2-enoic acid [4-(phenylamino)-quinazoline-6-yl]-amides: potential PET bioprobes for molecular imaging of EGFR-positive tumorsEyal Mishani, Galith Abourbeh, Yulia Rozen, et al.
Journal of Medicinal Chemistry|August 5, 2005
High-affinity epidermal growth factor receptor (EGFR) irreversible inhibitors with diminished chemical reactivities as positron emission tomography (PET)-imaging agent candidates of EGFR overexpressing tumorsEyal Mishani, Galith Abourbeh, Orit Jacobson, et al.
The Journal of Infectious Diseases|November 18, 2017
S101, an Inhibitor of Proliferating T Cells, Rescues Mice From Superantigen-Induced ShockAlexei Shir, Shoshana Klein, Idit Sagiv-Barfi, et al.
Nuclear Medicine and Biology|January 11, 2007
Evaluation of radiolabeled ML04, a putative irreversible inhibitor of epidermal growth factor receptor, as a bioprobe for PET imaging of EGFR-overexpressing tumorsGalith Abourbeh, Samar Dissoki, Orit Jacobson, et al.
Cancer Research|February 28, 2002
The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenesFrancesca Carlomagno, Donata Vitagliano, Teresa Guida, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
BMC Systems Biology|March 18, 2011
Convergence of logic of cellular regulation in different premalignant cells by an information theoretic approachNataly Kravchenko-Balasha, F Remacle, Ayelet Gross, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2002
Tyrosine kinase inhibitors suppress the growth of non-hodgkin B lymphomasHannah Ben-Bassat, Zipora Hartzstark, Rubina Levitzki, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2012
On a fundamental structure of gene networks in living cellsNataly Kravchenko-Balasha, Alexander Levitzki, Andrew Goldstein, et al.
Experimental and Molecular Pathology|May 6, 2004
The effect of early and late treatment with the tyrphostin AG-556 on the progression of experimental autoimmune myocarditisJacob George, Iris Barshack, Iris Goldberg, et al.
International Journal of Cancer|September 5, 2002
Labeled EGFr-TK irreversible inhibitor (ML03): in vitro and in vivo properties, potential as PET biomarker for cancer and feasibility as anticancer drugGiuseppina Ortu, Iris Ben-David, Yulia Rozen, et al.
Nuclear Medicine and Biology|April 20, 2004
Novel carbon-11 labeled 4-dimethylamino-but-2-enoic acid [4-(phenylamino)-quinazoline-6-yl]-amides: potential PET bioprobes for molecular imaging of EGFR-positive tumorsEyal Mishani, Galith Abourbeh, Yulia Rozen, et al.
Journal of Medicinal Chemistry|August 5, 2005
High-affinity epidermal growth factor receptor (EGFR) irreversible inhibitors with diminished chemical reactivities as positron emission tomography (PET)-imaging agent candidates of EGFR overexpressing tumorsEyal Mishani, Galith Abourbeh, Orit Jacobson, et al.
The Journal of Infectious Diseases|November 18, 2017
S101, an Inhibitor of Proliferating T Cells, Rescues Mice From Superantigen-Induced ShockAlexei Shir, Shoshana Klein, Idit Sagiv-Barfi, et al.
Nuclear Medicine and Biology|January 11, 2007
Evaluation of radiolabeled ML04, a putative irreversible inhibitor of epidermal growth factor receptor, as a bioprobe for PET imaging of EGFR-overexpressing tumorsGalith Abourbeh, Samar Dissoki, Orit Jacobson, et al.
Cancer Research|February 28, 2002
The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenesFrancesca Carlomagno, Donata Vitagliano, Teresa Guida, et al.
Pageof 10